Transient Worsening of Parkinson's Disease after Cigarette Smoking

Internal Medicine

Volumn 36, Issue 9, 1997, Pages 651-653

  Nishimura, Hiroyuki ^a   Tachibana, Hisao ^a   Okuda, Bungo ^a   Sugita, Minoru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Neurotransmitter; Nicotine

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; HUMAN; MALE; MUSCLE RIGIDITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; SMOKING; TIME; TREMOR;

ADULT; DISEASE PROGRESSION; HUMANS; MALE; MUSCLE RIGIDITY; NICOTINE; PARKINSON DISEASE; SMOKING; TIME FACTORS; TREMOR;

EID: 0031225443     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.651     Document Type: Article

References (17)

1. Spillane JD. The effect of nicotine on spinocerebellar ataxia. Br Med J 2: 1345, 1955.
2. Kessler II, Diamond EL. Epidemiologic studies of Parkinson's disease: I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. Am J Epidemiol 94: 16, 1971.
3. Kessler II. Epidemiologic studies of Parkinson's disease: III. A community based survey. Am J Epidemiol 96: 242, 1972.
4. Lichtensteiger W, Felix D, Lienhart R, Hefti F. A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine. Brain Res 117: 85, 1976.
5. Westfall TC. Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology 13: 693, 1974.
6. Ishikawa A, Miyatake T. Effects of smoking in patients with early-onset Parkinson's disease. J Neurol Sci 117: 28, 1993.
7. Niino M, Matumoto A, Yamada K, Tashiro K. Juvenile parkinsonism transiently worsened by smoking. Neurol Med 42: 553, 1995 (in Japanese).
8. Baron JA. Cigarette smoking and parkinson's disease. Neurology 36: 1490, 1986.
9. Morens DM, Grandinetti A, Reed D, White LR, Ross GW. Cigarette smoking and protection from parkinson's disease: False association or etiologic clue? Neurology 45: 1041, 1995.
10. Golbe LI, Cody RA, Duvoisin RC. Smoking and parkinson's disease: Search for a dose-response relationship. Arch Neurol 43: 774, 1986.
11. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 32 Suppl: S125, 1992.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181, 1992.
13. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 237: 197, 1990.
14. Jaffe JH. Drug addiction and drug abuse, in: The Pharmacological Basis of Therapeutics, Gilman AG, Goodman LS, Rall TW, Murad F, Eds. Macmillan, New York, 1985, p. 532.
15. Taylor P. Ganglionic stimulating and blocking agents, in:The Pharmacological Basis of Therapeutics. Gilman AG, Goodman LS, Rall TW, Murad F, Eds. Macmillan, New York, 1985, p. 215.
16. Aceto MD, Martin BR. Central actions of nicotine. Med Res Rev 2: 43, 1982.
17. Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing WW, Geffen LB. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27: 373, 1990.